一个新的深度学习技术多分类阿尔茨海默病:超参数优化技术
A S Elmotelb1, Fayroz F Sherif2, A S Abohamama3,4
1Department of Computer Science, Faculty of Computers and Informatics, Zagazig University, Zagazig, Egypt.
Frontiers in artificial intelligence
|May 9, 2025
概括
这项研究引入了一种新的深度学习方法,用于准确地分类阿尔茨海默病 (AD) 阶段. 新方法提高了早期检测,这对于及时干预和疾病管理至关重要.
科学领域:
- 神经学 神经学
- 人工智能的人工智能
- 医疗成像医学成像
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性大脑疾病,影响记忆和认知.
- 早期发现和分类AD阶段对于有效的治疗干预至关重要.
- 现有的方法面临着有限的数据和计算资源的挑战.
研究的目的:
- 开发一种新的深度学习方法,用于准确地分类阿尔茨海默病的阶段.
- 为了解决AD检测中的数据稀缺和计算需求的局限性.
- 提高分类阿尔茨海默病不同阶段的效率和有效性.
主要方法:
- 一种使用ResNet152V2模型的新型深度学习方法.
- 一种新提出的超参数优化技术,用于确定最佳模型参数.
- 与最先进的转移学习和经典模型进行比较.
主要成果:
- 提出的深度学习方法在分类AD阶段方面表现出卓越的表现.
- 该模型在回忆,精度,F1得分和准确性方面取得了很高的成绩.
- 这种方法被证明比现有的方法更有效和高效.
结论:
- 新的深度学习方法为准确的阿尔茨海默病阶段分类提供了一个有希望的解决方案.
- 这一进步支持早期诊断,使得及时的疾病管理策略成为可能.
- 优化的ResNet152V2模型有效地克服了数据和资源的限制.
更多相关视频
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.4K
06:32Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
Published on: July 14, 2023
1.1K
相关概念视频
01:26Alzheimer's Disease: Overview
328
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
328
01:22Alzheimer's Disease: Treatment
128
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
128